热门资讯> 正文

MediPharm Labs报告第一季度业绩

2026-05-13 19:34

MediPharm Labs press release (MEDIF): Q1 Adjusted EBITDA of $0.1 million
Revenue of $9M beats by $2.74M.
OPEX decreased 28% in Q1 2026 versus Q4 2025
International Medical revenue was $4.6 million, representing 51% of total revenue for the quarter.

More on MediPharm Labs Corp.

MediPharm Labs Corp. (LABS:CA) Q4 2025 Earnings Call Transcript
Historical earnings data for MediPharm Labs Corp.
Financial information for MediPharm Labs Corp.

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。